AffirmHealth Blog

dsuvia, FDA, Raeford Brown, Opioid Therapy, Opioid Epidemic

The Controversial Approval of Dsuvia by the Food and Drug Administration

Posted by Mario Ramirez, MD on Nov 21, 2018 8:23:13 AM

0 Comments

Earlier this month on November 2nd, the U.S. Food and Drug Administration approved Dsuvia, a new sublingual version of an older drug, sufentanil, that has been in use since 1984. 

READ MORE

 

The information presented on or through this website is made available solely for general information purposes and is not intended to substitute for professional, medical or legal advice. We do not warrant the accuracy, completeness, or usefulness of this information. Any reliance you place on such information is strictly at your own risk. We disclaim all liability and responsibility arising from any reliance placed on such materials.

PROTECT YOUR PATIENTS.
PROTECT YOUR PRACTICE.

Drive responsible, compliant opioid prescribing across your organization.

SCHEDULE A CALL

Comments

Categories

see all

Popular Posts